NemaGen Discoveries is an early phase biotech company focused on advancing therapies for patients suffering from allergic inflammation and mast cell-related diseases.
NemaGen was founded by Mark C. Siracusa Ph.D. an expert in the fields of parasitology and immunology. Dr. Siracusa has partnered with experts in the advancement of early phase biotech companies and has established an experienced and results-driven team.
NemaGen's novel technologies were developed by investigating the bodies natural ability to prevent unwanted inflammation following parasitic infections. By taking this unique approach NemaGen has pioneered new therapeutics strategies to help patients suffering diverse inflammatory diseases.
NemaGen is looking to hire a highly motivated PhD level scientist with a desire to advance new life science technologies in an exciting and fast-paced startup environment. The purpose of the position is to assist with the research development and business operations of NemaGen. Responsibilities will primarily include serving as the PI on a SBIR/STTR grant, supervision and execution of research activities, monitoring project costs, assisting with operational and business decisions, and maintaining collaborations with partners..
NemaGen's exciting findings have defined a previously unappreciated neuropeptide pathway that prevents unwanted lung inflammation. These studies were recently published in Nature Immunology. https://www.nature.com/articles/s41590-020-0753-y